Funding for this research was provided by:
Xi’an Innovation Capability Strengthening Foundation Program (22YXYJ0019)
Key Research and Development Projects of Shaanxi Province (2023-YBSF-069)
Article History
Received: 11 March 2023
Accepted: 15 June 2023
First Online: 17 June 2023
Declarations
:
: This retrospective study protocol was approved (approval no.: 2021–01007) by the Institutional Review Board of Honghui Hospital, Xi’an Jiao Tong University (Honghui Hospital, Xi’an Jiaotong University, Xi’an, Shaanxi Province, China). The study protocol was performed in accordance with the Declaration of Helsinki and laws and regulations of the countries in which the clinical study was conducted, including data protection laws, the Clinical Investigation Agreement and the Clinical Investigation Plan. In this retrospective study, only medical records and case information were analysed, no patients were directly involved in setting the research questions or the outcome measures, and patient information was anonymized; therefore, written inform consent was waived by Honghui Hospital, Xi’an Jiao Tong University Health Science Centre Biomedical research ethic committee.
: Not applicable.
: The authors declare no competing interests.